0.011116 0.000000 0.000000 0.000000 0.011116 0.000000 0.000000 0.000000 0.011116 0.00000 0.00000 0.00000 RESIDUES 18 AND 44 ARE CIS-PROLINES. Chen, P. Rose, J. Wang, B.C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 24 90.00 90.00 90.00 89.960 89.960 89.960 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 267 1990 1994 1730730 Reactive sites of an anticarcinogenic Bowman-Birk proteinase inhibitor are similar to other trypsin inhibitors. 1992 US J.Biol.Chem. JBCHA3 0071 0021-9258 258 9357 Crystallization of Two Cubic Forms of Soybean Trypsin Inhibitor E-I, a Member of the Bowman-Birk Inhibitor Family 1983 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 7213.337 BOWMAN-BIRK INHIBITOR (PI-II) 1 man polymer no no DEYSKPCCDLCMCTRSMPPQCSCEDRINSCHSDCKSCMCTRSQPGQCRCLDTNDFCYKPCKSR DEYSKPCCDLCMCTRSMPPQCSCEDRINSCHSDCKSCMCTRSQPGQCRCLDTNDFCYKPCKSR A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n soybean Glycine sample 3847 Glycine max 4.20 70.73 repository Initial release Version format compliance Version format compliance 1 0 1992-04-15 1 1 2008-03-24 1 2 2011-07-13 Y 1991-03-26 REL n 1 1 A n 2 2 A TYR 3 n 3 TYR 3 A SER 4 n 4 SER 4 A LYS 5 n 5 LYS 5 A PRO 6 n 6 PRO 6 A CYS 7 n 7 CYS 7 A CYS 8 n 8 CYS 8 A ASP 9 n 9 ASP 9 A LEU 10 n 10 LEU 10 A CYS 11 n 11 CYS 11 A MET 12 n 12 MET 12 A CYS 13 n 13 CYS 13 A THR 14 n 14 THR 14 A ARG 15 n 15 ARG 15 A SER 16 n 16 SER 16 A MET 17 n 17 MET 17 A PRO 18 n 18 PRO 18 A PRO 19 n 19 PRO 19 A GLN 20 n 20 GLN 20 A CYS 21 n 21 CYS 21 A SER 22 n 22 SER 22 A CYS 23 n 23 CYS 23 A GLU 24 n 24 GLU 24 A ASP 25 n 25 ASP 25 A ARG 26 n 26 ARG 26 A ILE 27 n 27 ILE 27 A ASN 28 n 28 ASN 28 A SER 29 n 29 SER 29 A CYS 30 n 30 CYS 30 A HIS 31 n 31 HIS 31 A SER 32 n 32 SER 32 A ASP 33 n 33 ASP 33 A CYS 34 n 34 CYS 34 A LYS 35 n 35 LYS 35 A SER 36 n 36 SER 36 A CYS 37 n 37 CYS 37 A MET 38 n 38 MET 38 A CYS 39 n 39 CYS 39 A THR 40 n 40 THR 40 A ARG 41 n 41 ARG 41 A SER 42 n 42 SER 42 A GLN 43 n 43 GLN 43 A PRO 44 n 44 PRO 44 A GLY 45 n 45 GLY 45 A GLN 46 n 46 GLN 46 A CYS 47 n 47 CYS 47 A ARG 48 n 48 ARG 48 A CYS 49 n 49 CYS 49 A LEU 50 n 50 LEU 50 A ASP 51 n 51 ASP 51 A THR 52 n 52 THR 52 A ASN 53 n 53 ASN 53 A ASP 54 n 54 ASP 54 A PHE 55 n 55 PHE 55 A CYS 56 n 56 CYS 56 A TYR 57 n 57 TYR 57 A LYS 58 n 58 LYS 58 A PRO 59 n 59 PRO 59 A CYS 60 n 60 CYS 60 A LYS 61 n 61 LYS 61 A SER 62 n 62 SER 62 A ARG 63 n 63 ARG 63 A author_defined_assembly 6 hexameric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 0.0000000000 -1.0000000000 0.0000000000 19_555 -x+3/4,-z+3/4,-y+3/4 crystal symmetry operation 67.4700000000 67.4700000000 67.4700000000 0.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 -1.0000000000 0.0000000000 0.0000000000 10_655 -y+1,z+1/2,-x+1/2 crystal symmetry operation 89.9600000000 44.9800000000 44.9800000000 0.0000000000 0.0000000000 -1.0000000000 -1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 7_564 -z+1/2,-x+1,y-1/2 crystal symmetry operation 44.9800000000 89.9600000000 -44.9800000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 -1.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 22_564 z+1/4,-y+5/4,x-1/4 crystal symmetry operation 22.4900000000 112.4500000000 -22.4900000000 0.0000000000 1.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 13_455 y-1/4,x+1/4,-z+1/4 crystal symmetry operation -22.4900000000 22.4900000000 22.4900000000 1 A OG SER 62 A OG SER 62 1 Y 1 A CG ARG 63 A CG ARG 63 1 Y 1 A CD ARG 63 A CD ARG 63 1 Y 1 A NE ARG 63 A NE ARG 63 1 Y 1 A CZ ARG 63 A CZ ARG 63 1 Y 1 A NH1 ARG 63 A NH1 ARG 63 1 Y 1 A NH2 ARG 63 A NH2 ARG 63 1 Y 1 A ASP 1 A ASP 1 1 Y 1 A GLU 2 A GLU 2 1 Y 1 9.10 1.40 123.60 132.70 A A A CD NE CZ ARG ARG ARG 15 15 15 N 1 8.78 1.10 114.20 122.98 A A A CA CB SG CYS CYS CYS 21 21 21 N 1 -15.31 1.80 110.60 95.29 A A A N CA CB CYS CYS CYS 23 23 23 N 1 19.94 2.70 111.00 130.94 A A A N CA C CYS CYS CYS 23 23 23 N 1 -13.95 1.60 122.70 108.75 A A A O C N CYS CYS GLU 23 23 24 Y 1 17.51 2.50 121.70 139.21 A A A C N CA CYS GLU GLU 23 24 24 Y 1 -12.86 2.00 110.40 97.54 A A A CB CA C GLU GLU GLU 24 24 24 N 1 18.03 2.50 121.70 139.73 A A A C N CA GLU ASP ASP 24 25 25 Y 1 11.80 0.90 118.30 130.10 A A A CB CG OD1 ASP ASP ASP 25 25 25 N 1 -9.96 0.90 118.30 108.34 A A A CB CG OD2 ASP ASP ASP 25 25 25 N 1 17.25 2.70 111.00 128.25 A A A N CA C ASP ASP ASP 25 25 25 N 1 5.76 0.50 120.30 126.06 A A A NE CZ NH1 ARG ARG ARG 26 26 26 N 1 -3.70 0.50 120.30 116.60 A A A NE CZ NH2 ARG ARG ARG 26 26 26 N 1 10.61 1.40 123.60 134.21 A A A CD NE CZ ARG ARG ARG 41 41 41 N 1 4.81 0.50 120.30 125.11 A A A NE CZ NH1 ARG ARG ARG 41 41 41 N 1 A A N O GLN GLN 43 43 1.66 1_555 19_555 1 A A N O ARG CYS 15 37 2.08 1_555 10_655 1 A ARG 15 -79.23 33.62 1 A CYS 23 -131.29 -129.51 1 A ASN 28 77.09 -34.88 1 A SER 62 -179.14 -64.08 0.236 2.5 1 2.5 0 461 0 0 461 0.012 2.8 refinement GPRLSA BOWMAN-BIRK PROTEINASE INHIBITOR PI-II REACTIVE SITES OF AN ANTICARCINOGENIC BOWMAN-BIRK PROTEINASE INHIBITOR ARE SIMILAR TO OTHER TRYPSIN INHIBITORS 1 N N disulf 1.944 A CYS 7 A SG CYS 7 1_555 A CYS 60 A SG CYS 60 1_555 disulf 1.980 A CYS 8 A SG CYS 8 1_555 A CYS 23 A SG CYS 23 1_555 disulf 2.076 A CYS 11 A SG CYS 11 1_555 A CYS 56 A SG CYS 56 1_555 disulf 2.025 A CYS 13 A SG CYS 13 1_555 A CYS 21 A SG CYS 21 1_555 disulf 1.920 A CYS 30 A SG CYS 30 1_555 A CYS 37 A SG CYS 37 1_555 disulf 1.992 A CYS 34 A SG CYS 34 1_555 A CYS 49 A SG CYS 49 1_555 disulf 2.008 A CYS 39 A SG CYS 39 1_555 A CYS 47 A SG CYS 47 1_555 SERINE PROTEINASE INHIBITOR SERINE PROTEINASE INHIBITOR A MET 17 A MET 17 1 A PRO 18 A PRO 18 -4.05 A GLN 43 A GLN 43 1 A PRO 44 A PRO 44 0.11 IBBD2_SOYBN UNP 1 1 P01064 MCILSFLKSDQSSSYDDDEYSKPCCDLCMCTRSMPPQCSCEDIRLNSCHSDCKSCMCTRSQPGQCRCLDTNDFCYKPCKS RDD 18 81 1PI2 1 63 P01064 A 1 1 63 1 ILE DELETION 1PI2 A P01064 UNP 43 1 LEU CONFLICT ILE 27 1PI2 A P01064 UNP 45 27 2 2 anti-parallel anti-parallel A CYS 11 A CYS 11 A ARG 15 A ARG 15 A GLN 20 A GLN 20 A ILE 27 A ILE 27 A SER 36 A SER 36 A THR 40 A THR 40 A GLN 46 A GLN 46 A ASN 53 A ASN 53 213 P 41 3 2